Tian Fei, Shen Yanting, Chen Zhenzhu, Li Rui, Ge Qinyu
Research Center for Learning Science, Southeast University, Sipailou No. 2, Nanjing, Jiangsu 210096, China.
State Key Lab of Bioelectronics, Southeast University, Nanjing 210096, China.
Biomed Res Int. 2017;2017:1304816. doi: 10.1155/2017/1304816. Epub 2017 Jun 1.
MicroRNAs (miRNAs) are small noncoding RNAs that are involved in many biological regulation processes. Studies have reported that miRNAs are enriched in human plasma and plasma-derived exosome as novel diagnostic biomarkers. The aim of this study was to determine whether the miRNA expression levels are different between plasma and plasma-derived exosome.
We sequenced and quantified the miRNAs in plasma and exosome from healthy blood samples and validated three miRNAs in the two groups of lung cancer samples by qRT-PCR.
The sequencing results showed that only several of miRNAs were differential, while the qRT-PCR further validated that most of them did not have the consistent differences. However, the levels of two upregulated miRNAs (miR-181b-5p and miR-21-5p) in lung cancer were significantly higher in exosomes than plasma.
To the best of our knowledge, this study is the first to compare the expression levels of miRNAs between plasma and exosome in healthy blood samples. Our data suggested that the miRNA levels were similar in the two parts of the healthy people, whereas the two onco-miRNAs were significantly enriched in the exosome of lung cancer patients.
微小RNA(miRNA)是参与多种生物调节过程的小非编码RNA。研究报道,miRNA作为新型诊断生物标志物在人血浆和血浆来源的外泌体中富集。本研究的目的是确定血浆和血浆来源的外泌体之间miRNA表达水平是否存在差异。
我们对健康血液样本中的血浆和外泌体中的miRNA进行测序和定量,并通过qRT-PCR在两组肺癌样本中验证了三种miRNA。
测序结果显示只有几种miRNA存在差异,而qRT-PCR进一步验证其中大多数没有一致的差异。然而,肺癌中两种上调的miRNA(miR-181b-5p和miR-21-5p)在外泌体中的水平明显高于血浆。
据我们所知,本研究首次比较了健康血液样本中血浆和外泌体之间miRNA的表达水平。我们的数据表明,健康人这两部分中的miRNA水平相似,而两种癌miRNA在肺癌患者的外泌体中显著富集。